Diagnostic chain Neuberg Diagnostics—where Velu serves as chairman—is likely to be the first to list, followed by Maxivision Eye Hospitals and then medtech firm Trivitron Healthcare, where he is chairman and managing director.
G.S.K. Velu’s Maxivision eyes west India push ahead of listing next year
